Gelteq GELS
NASDAQ GELS
$0.53 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gelteq (GELS) Current Deferred Revenue (2023 - 2024)

Updated

Gelteq's Current Deferred Revenue came in at $77,627 for the quarter ended Dec 31, 2024.

Analysis

Gelteq (GELS) Current Deferred Revenue (2023 - 2024) Analysis & Trends

As of Jun 30, 2024, Gelteq's Current Deferred Revenue was $82,615, up 44.8% from the prior year.

  • Going back by year, Current Deferred Revenue was $57,051 in the year ended Jun 30, 2023.
  • The figure for the quarter ended Dec 31, 2024 represents the lowest quarterly Current Deferred Revenue since the quarter ended Jun 30, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.26 Bn 36.10 Bn 1.44 Bn
2 Medpace Holdings 17.42 Bn 15.48 Bn 201.64 Mn
3 Charles River Laboratories International 14.08 Bn 13.32 Bn 363.37 Mn
4 Icon 13.02 Bn 10.12 Bn 479.29 Mn
5 Fortrea Holdings 1.90 Bn 1.28 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 817.41 Mn 55.33 Mn 18.44 Mn
7 Evotec SE 608.00 Mn -965.22 Mn -
8 Champions Oncology 69.59 Mn 45.24 Mn 7.70 Mn
9 MindWalk Holdings 62.13 Mn 26.34 Mn 1.61 Mn
10 Gelteq 5.68 Mn 3.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 77,627.26
Jun 30, 2024 82,614.65
Jun 30, 2023 57,050.58
API Access

Gelteq Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GELS&period=max&api_key=YOUR_API_KEY